Healthcare Sector
Biotechnology & Drugs Industry 
|
|
|
Data by Company within Biotechnology & Drugs Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Avalanche Biotechnologies, Inc. |
- |
- |
$ 0 |
- |
| Abbvie Inc. |
$ 119,360 |
$ 32,753 |
$ 5,687 |
26,000 |
| Arca Biopharma, Inc. |
$ 5 |
- |
$ -8 |
- |
| American Bio Medica Corp |
$ 3 |
$ 4 |
$ -1 |
- |
| Acorda Therapeutics Inc |
$ 620 |
$ 589 |
$ -158 |
- |
| Aclaris Therapeutics, Inc. |
$ 238 |
$ 10 |
$ -133 |
- |
| Actavis Plc |
$ 4,377 |
$ 10,573 |
$ -751 |
19,200 |
| Ocata Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Adaptimmune Therapeutics Plc |
$ 4,320 |
$ 60 |
$ -70 |
- |
| Fennec Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Adma Biologics, Inc. |
$ 154 |
$ 17 |
$ -66 |
- |
| Adverum Biotechnologies, Inc. |
$ 344 |
$ 2 |
$ -65 |
- |
| Aerie Pharmaceuticals Inc |
$ 2,116 |
- |
$ -233 |
- |
| Agenus Inc |
$ 340 |
$ 37 |
$ -162 |
- |
| Allergan Plc |
$ 49,078 |
$ 15,787 |
$ -5,086 |
10,500 |
| Applied Genetic Technologies Corp |
$ 76 |
$ 29 |
$ -18 |
- |
| Akers Biosciences, Inc. |
$ 13 |
$ 2 |
$ -11 |
- |
| Alder Biopharmaceuticals Inc |
$ 885 |
- |
$ -326 |
- |
| Alliance Bioenergy Plus, Inc. |
$ 1 |
- |
$ -10 |
- |
| Amarillo Biosciences Inc |
$ 13 |
$ 0 |
$ -1 |
- |
| Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
| Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
| Amgen Inc |
$ 142,928 |
$ 32,341 |
$ 5,081 |
17,900 |
| Albany Molecular Research Inc |
$ 928 |
$ 681 |
$ -60 |
- |
| Amyris, Inc. |
$ 137 |
$ 142 |
$ -152 |
440 |
| Alpha Network Alliance Ventures Inc. |
- |
$ 0 |
$ 0 |
7 |
| Aeolus Pharmaceuticals, Inc. |
$ 0 |
$ 1 |
$ -4 |
- |
| Ampliphi Biosciences Corp |
$ 5 |
$ 0 |
$ -10 |
- |
| Aptevo Therapeutics Inc. |
$ 21 |
$ 23 |
$ -54 |
- |
| Ariad Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Arno Therapeutics, Inc |
- |
- |
$ 0 |
- |
| Assembly Biosciences, Inc. |
$ 465 |
$ 15 |
$ -91 |
- |
| Asterias Biotherapeutics, Inc. |
$ 52 |
$ 1 |
$ -20 |
- |
| Atara Biotherapeutics, Inc. |
$ 1,717 |
- |
$ -231 |
- |
| Kubota Pharmaceutical Holdings Co Ltd |
- |
- |
$ 0 |
- |
| Aviragen Therapeutics, Inc. |
$ 32 |
$ 8 |
$ -19 |
- |
| Anavex Life Sciences Corp. |
$ 135 |
$ 0 |
$ -3 |
- |
| Axim Biotechnologies, Inc. |
$ 90 |
$ 0 |
$ -7 |
- |
| Axovant Sciences Ltd. |
$ 157 |
- |
$ -145 |
- |
| Aytu Bioscience, Inc |
$ 12 |
$ 5 |
$ -10 |
- |
| Azurrx Biopharma, Inc. |
$ 38 |
- |
$ -12 |
- |
| Brainstorm Cell Therapeutics Inc. |
$ 85 |
- |
$ -8 |
- |
| Biocryst Pharmaceuticals Inc |
$ 811 |
$ 21 |
$ -101 |
- |
| Beesfree, Inc. |
- |
- |
$ 0 |
- |
| Bg Medicine, Inc. |
- |
- |
$ 0 |
- |
| U.s. Stem Cell, Inc. |
- |
$ 7 |
$ -2 |
- |
| Premier Biomedical Inc |
$ 0 |
$ 0 |
$ -1 |
- |
| Biogen Idec Inc. |
$ 52,386 |
$ 6,932 |
$ 1,862 |
7,550 |
| Immucor Inc |
- |
- |
$ 0 |
- |
| Bluebird Bio, Inc. |
$ 8,032 |
$ 55 |
$ -556 |
- |
| Mj Biotech, Inc. |
- |
- |
$ -15 |
2 |
| Bionovo Inc |
- |
- |
$ 0 |
- |
| Audentes Therapeutics, Inc. |
$ 1,568 |
- |
$ -129 |
- |
| Bohai Pharmaceuticals Group, Inc. |
$ 7 |
$ 165 |
$ 22 |
- |
| Biota Pharmaceuticals, Inc. |
- |
$ 53 |
$ -13 |
- |
| Biopharmx Corp |
$ 19 |
$ 0 |
$ -17 |
- |
| Bespoke Tricycles Inc |
$ 8 |
$ 1 |
$ -9 |
- |
| Biorestorative Therapies, Inc. |
$ 6 |
$ 0 |
$ -11 |
- |
| Boston Therapeutics, Inc. |
$ 4 |
$ 0 |
$ -2 |
- |
| Biotime Inc |
$ 198 |
$ 5 |
$ -47 |
- |
| Burzynski Research Institute Inc |
$ 4 |
- |
$ -2 |
- |
| Cadence Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| General Cannabis Corp |
$ 122 |
$ 4 |
$ -17 |
- |
| Capricor Therapeutics, Inc. |
$ 18 |
$ 2 |
$ 0 |
- |
| Capstone Therapeutics Corp. |
$ 2 |
- |
$ 0 |
- |
| Casi Pharmaceuticals, Inc. |
$ 101 |
- |
$ 10 |
- |
| Catalyst Biosciences, Inc. |
$ 102 |
$ 1 |
$ -30 |
- |
| Cellular Biomedicine Group, Inc. |
$ 321 |
$ 0 |
$ -39 |
- |
| China Botanic Pharmaceutical |
- |
- |
$ 0 |
- |
| China Biologic Products Holdings, Inc. |
$ 3,164 |
$ 467 |
$ 148 |
- |
| Cellcyte Genetics Corp. |
- |
- |
$ 0 |
- |
| Cidara Therapeutics, Inc. |
$ 72 |
- |
$ -59 |
- |
| Chromadex Corp. |
$ 218 |
$ 32 |
$ -33 |
- |
| Cardax, Inc. |
$ 2 |
$ 1 |
$ -4 |
- |
| Cen Biotech Inc |
- |
- |
$ -15 |
- |
| Cerecor Inc. |
$ 229 |
$ 18 |
$ -42 |
- |
| Compugen Ltd |
$ 200 |
$ 18 |
$ -23 |
- |
| Coherus Biosciences, Inc. |
$ 916 |
$ 178 |
$ -196 |
- |
| Chelsea Therapeutics International, Ltd. |
- |
- |
$ 0 |
- |
| China Kangtai Cactus Bio-tech, Inc. |
- |
- |
$ 0 |
- |
| Celladon Corporation |
- |
- |
$ 0 |
- |
| Celldex Therapeutics, Inc. |
$ 728 |
$ 10 |
$ -151 |
- |
| Cell Medx Corp. |
$ 7 |
$ 0 |
$ -1 |
4 |
| Myskin, Inc. |
- |
$ 4 |
$ -24 |
- |
| Cannabics Pharmaceuticals Inc. |
- |
$ 0 |
$ -4 |
- |
| Compass Biotechnologies Inc. |
- |
- |
$ 0 |
- |
| Cohbar, Inc. |
- |
- |
$ -10 |
- |
| Cocrystal Pharma, Inc. |
$ 84 |
- |
$ 0 |
- |
| Core Lithium Corp. |
$ 85 |
- |
$ -4 |
- |
| Golden Dragon Holding Co. |
$ 26 |
- |
$ -11 |
- |
| Curis Inc |
$ 47 |
$ 11 |
$ -35 |
- |
| Crispr Therapeutics Ag |
$ 1,842 |
$ 3 |
$ -165 |
- |
| American Cryostem Corp |
$ 19 |
$ 0 |
$ -2 |
- |
| Champions Oncology, Inc. |
$ 116 |
$ 24 |
$ 0 |
- |
| Ctd Holdings Inc |
$ 53 |
$ 1 |
$ -4 |
6 |
| Cellceutix Corp |
$ 88 |
- |
$ -7 |
- |
| Cytomx Therapeutics, Inc. |
$ 491 |
$ 62 |
$ -74 |
- |
| Trail One, Inc. |
$ 2 |
- |
$ -13 |
1 |
| Neuralstem, Inc. |
$ 9 |
$ 0 |
$ -5 |
- |
| Cel Sci Corp |
$ 147 |
- |
$ -12 |
- |
| Cv Sciences, Inc. |
- |
$ 40 |
$ 7 |
- |
| Cyanotech Corp |
$ 19 |
$ 29 |
$ 3 |
124 |
| Cytodyn Inc. |
$ 131 |
- |
$ -56 |
- |
| Cytrx Corp |
$ 25 |
- |
$ -15 |
- |
| Putnam Hills Corp. |
$ 30 |
- |
$ -2 |
- |
| Diadexus, Inc. |
- |
- |
$ 0 |
- |
| Diffusion Pharmaceuticals Inc. |
$ 238 |
- |
$ -27 |
- |
| Delmar Pharmaceuticals, Inc. |
$ 22 |
- |
$ 0 |
- |
| Dimension Therapeutics, Inc. |
$ 149 |
$ 17 |
$ -56 |
- |
| Dna Testing Centers Corp |
- |
$ 0 |
$ 0 |
- |
| Dendreon Corp |
- |
- |
$ 0 |
- |
| Noho, Inc. |
- |
- |
$ 0 |
- |
| Windtree Therapeutics Inc |
- |
- |
$ 0 |
- |
| Ds Healthcare Group, Inc. |
$ 0 |
$ 12 |
$ -6 |
105 |
| Emergent Biosolutions Inc. |
$ 2,579 |
$ 782 |
$ 63 |
- |
| Edge Therapeutics, Inc. |
$ 16 |
- |
$ -41 |
- |
| Eiger Biopharmaceuticals, Inc. |
$ 250 |
- |
$ -52 |
- |
| Empowered Products, Inc. |
- |
- |
$ 0 |
- |
| Endonovo Therapeutics, Inc. |
$ 7 |
- |
$ -6 |
- |
| Entremed Inc |
- |
- |
$ 0 |
- |
| Entest Group, Inc. |
$ 2 |
- |
$ 0 |
- |
| Enumeral Biomedical Holdings, Inc. |
$ 0 |
$ 2 |
$ -13 |
- |
| Enzon Pharmaceuticals, Inc. |
$ 11 |
$ 7 |
$ 6 |
- |
| Enzymotec Ltd. |
- |
- |
$ 0 |
124 |
| Entia Biosciences, Inc. |
$ 0 |
$ 0 |
$ -1 |
- |
| Eastgate Biotech Corp |
- |
$ 0 |
$ -4 |
- |
| Fate Therapeutics Inc |
$ 875 |
$ 4 |
$ -63 |
- |
| Fennec Pharmaceuticals Inc. |
$ 175 |
- |
$ -10 |
- |
| Fulgent Genetics, Inc. |
$ 100 |
$ 21 |
$ -6 |
- |
| Foamix Pharmaceuticals Ltd. |
$ 213 |
$ 4 |
$ 74 |
68 |
| Global Future City Holding Inc. |
$ 3 |
$ 3 |
$ -5 |
- |
| Galena Biopharma, Inc. |
$ 10 |
- |
$ -32 |
- |
| Gentium S.p.a. |
- |
- |
$ 0 |
- |
| Synageva Biopharma Corp |
- |
- |
$ 0 |
- |
| Gilead Sciences Inc |
$ 82,736 |
$ 22,127 |
$ 5,460 |
7,000 |
| Glucose Health, Inc. |
$ 1 |
- |
$ 0 |
1 |
| Genocea Biosciences, Inc. |
$ 97 |
- |
$ -22 |
- |
| Aevi Genomic Medicine, Inc. |
$ 13 |
- |
$ -33 |
- |
| Green Planet Bio Engineering Co. Ltd. |
$ 1 |
- |
$ 0 |
- |
| Optec International, Inc. |
$ 54 |
$ 0 |
$ -5 |
- |
| Guided Therapeutics Inc |
$ 0 |
$ 0 |
$ -3 |
- |
| Genethera Inc |
$ 0 |
- |
$ -1 |
- |
| Gtx Inc |
$ 29 |
- |
$ -38 |
- |
| Gtx Corp |
$ 0 |
$ 1 |
$ -2 |
- |
| Green Vision Biotechnology Corp. |
- |
$ 0 |
$ -4 |
- |
| Halozyme Therapeutics Inc |
$ 1,759 |
$ 55 |
$ -83 |
- |
| Hubei Minkang Pharmaceutical Ltd. |
- |
- |
$ 0 |
- |
| Health Discovery Corp |
- |
- |
$ 0 |
- |
| Hemispherx Biopharma Inc |
$ 8 |
$ 0 |
$ -10 |
- |
| Hedgepath Pharmaceuticals, Inc. |
$ 32 |
- |
$ -4 |
- |
| Hyperion Therapeutics Inc |
- |
- |
$ 0 |
- |
| Heska Corp |
$ 703 |
$ 127 |
$ 6 |
- |
| Hst Global, Inc. |
$ 0 |
- |
$ 0 |
- |
| Idera Pharmaceuticals, Inc. |
$ 74 |
$ 1 |
$ -60 |
- |
| Igi Laboratories, Inc |
- |
- |
$ 0 |
- |
| Intelgenx Technologies Corp. |
$ 56 |
$ 2 |
$ -10 |
- |
| Intellect Neurosciences, Inc. |
$ 0 |
- |
$ -15 |
- |
| Conversion Labs, Inc. |
$ 10 |
$ 6 |
$ 0 |
11 |
| Epicure Charcoal, Inc. |
$ 0 |
- |
$ 0 |
- |
| Immunomedics Inc |
$ 1,862 |
$ 10 |
$ -388 |
- |
| Immune Therapeutics, Inc. |
$ 3 |
- |
$ -11 |
- |
| Integrated Biopharma Inc |
$ 4 |
$ 45 |
$ 2 |
- |
| Infinity Pharmaceuticals, Inc. |
$ 100 |
- |
$ -11 |
23 |
| Artemis Therapeutics, Inc. |
- |
- |
$ 1 |
1 |
| Innovus Pharmaceuticals, Inc. |
$ 10 |
$ 22 |
$ -8 |
- |
| Renovacare, Inc. |
- |
- |
$ -3 |
- |
| Jounce Therapeutics, inc. |
$ 197 |
$ 65 |
$ 0 |
- |
| Juno Therapeutics, Inc. |
$ 9,815 |
$ 112 |
$ -437 |
- |
| Cadus Corp |
$ 42 |
- |
$ -3 |
- |
| Kite Pharma, Inc. |
$ 10,187 |
$ 32 |
$ -359 |
- |
| Lion Biotechnologies, Inc. |
$ 433 |
- |
$ -67 |
- |
| Lescarden Inc |
- |
- |
$ 0 |
- |
| Atyr Pharma Inc |
$ 15 |
- |
$ -40 |
- |
| Lixte Biotechnology Holdings, Inc. |
$ 52 |
- |
$ -2 |
- |
| La Jolla Pharmaceutical Co |
$ 179 |
$ 10 |
$ -199 |
- |
| Lightlake Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Lazuriton Nano Biotechnology (u.s.a.) Inc. |
- |
- |
$ 0 |
- |
| Apollo Endosurgery, Inc. |
- |
$ 64 |
$ -28 |
- |
| Mateon Therapeutics Inc |
- |
- |
$ 0 |
- |
| Mabvax Therapeutics Holdings, Inc. |
$ 2 |
- |
$ -20 |
- |
| Multicell Technologies, Inc. |
$ 0 |
$ 0 |
$ -1 |
- |
| Microchannel Technologies Corp |
$ 2 |
- |
$ 0 |
- |
| Medgenics, Inc. |
- |
- |
$ -17 |
- |
| Enochian Biosciences Inc |
$ 253 |
- |
$ -20 |
- |
| Manhattan Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Mirna Therapeutics, Inc. |
$ 36 |
- |
$ -28 |
- |
| Micromet, Inc. |
- |
- |
$ 0 |
- |
| Mj Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Cure Pharmaceutical Holding Corp. |
- |
$ 0 |
$ 7 |
1 |
| Momenta Pharmaceuticals Inc |
$ 1,066 |
$ 76 |
$ -176 |
- |
| Mount Tam Biotechnologies, Inc. |
$ 1 |
- |
$ -2 |
- |
| Marina Biotech, Inc. |
$ 206 |
- |
$ -10 |
- |
| Myriad Genetics Inc |
$ 2,543 |
$ 737 |
$ 188 |
- |
| Mymetics Corp |
- |
$ 1 |
$ -4 |
- |
| Myokardia Inc |
$ 2,394 |
$ 34 |
$ -61 |
- |
| Myrexis, Inc. |
- |
- |
$ 0 |
- |
| Navidea Biopharmaceuticals, Inc. |
$ 27 |
$ 1 |
$ -16 |
- |
| Nascent Biotech Inc. |
$ 5 |
- |
$ -2 |
- |
| Neurocrine Biosciences Inc |
$ 5,732 |
$ 24 |
$ -34 |
- |
| Caladrius Biosciences, Inc. |
- |
$ 36 |
$ -16 |
- |
| Northsight Capital, Inc. |
- |
$ 0 |
$ -2 |
- |
| Neogen Corp |
$ 3,090 |
$ 412 |
$ 65 |
- |
| Nexus Biopharma Inc |
- |
- |
$ 0 |
- |
| Nantkwest, Inc. |
$ 100 |
$ 0 |
$ -96 |
- |
| Nile Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Biovie Inc. |
- |
- |
$ -2 |
- |
| Nutra Pharma Corp. |
$ 1 |
$ 0 |
$ -7 |
- |
| Nanostring Technologies Inc |
$ 725 |
$ 107 |
$ -77 |
- |
| Intellia Therapeutics, Inc. |
$ 715 |
$ 30 |
$ -85 |
- |
| Nbty Inc |
- |
- |
$ 0 |
- |
| Nugene International, Inc. |
- |
- |
$ 0 |
8 |
| Nutrastar International Inc. |
- |
- |
$ 0 |
- |
| Novavax Inc |
$ 208 |
$ 34 |
$ -185 |
- |
| N-viro International Corporation |
- |
- |
$ 0 |
- |
| Obalon Therapeutics Inc |
$ 36 |
$ 9 |
$ -37 |
- |
| Oncbiomune Pharmaceuticals, Inc |
$ 2 |
$ 0 |
$ -7 |
- |
| Oncocyte Corp |
$ 148 |
- |
$ -1 |
- |
| Spark Therapeutics, Inc. |
$ 4,257 |
$ 65 |
$ 0 |
- |
| Outlook Therapeutics, Inc. |
$ 51 |
$ 3 |
$ -39 |
- |
| Organovo Holdings, Inc. |
$ 83 |
$ 1 |
$ -29 |
- |
| Ophthalix, Inc. |
$ 2 |
- |
$ 1 |
- |
| Opiant Pharmaceuticals, Inc. |
$ 51 |
$ 14 |
$ -21 |
- |
| American Liberty Petroleum Corp. |
- |
- |
$ 0 |
- |
| Orgenesis Inc. |
$ 256 |
$ 19 |
$ 6 |
- |
| Osiris Therapeutics, Inc. |
$ 661 |
$ 91 |
$ 44 |
- |
| Oncovista Innovative Therapies, Inc |
- |
- |
$ 0 |
- |
| Oxford Immunotec Global Plc |
$ 457 |
$ 87 |
$ -16 |
- |
| Mateon Therapeutics Inc |
- |
- |
$ -5 |
- |
| Gt Biopharma, Inc. |
$ 3 |
- |
$ -261 |
- |
| Prolor Biotech, Inc. |
- |
- |
$ 0 |
- |
| Procyon Corporation |
$ 2 |
$ 3 |
$ 0 |
- |
| Pdl Biopharma, Inc. |
$ 507 |
$ 198 |
$ -69 |
- |
| Quint Media Inc. |
- |
- |
$ 0 |
- |
| Technologies Scan Corp. |
$ 50 |
$ 0 |
$ -1 |
4 |
| Protokinetix, Inc. |
$ 19 |
- |
$ -1 |
- |
| Pulse Biosciences, Inc. |
$ 564 |
$ 1 |
$ -53 |
- |
| Protalix Biotherapeutics, Inc. |
$ 67 |
$ 19 |
$ -85 |
- |
| Pharmacyte Biotech, Inc. |
$ 55 |
- |
$ -4 |
- |
| Proteon Therapeutics Inc |
$ 64 |
- |
$ -21 |
- |
| Pluristem Therapeutics Inc |
$ 60 |
$ 1 |
$ -29 |
- |
| Proteo Inc |
$ 1 |
$ 0 |
$ 0 |
- |
| Protagonist Therapeutics, Inc |
$ 392 |
- |
$ -37 |
- |
| Proteostasis Therapeutics, Inc. |
$ 235 |
$ 3 |
$ -61 |
- |
| Pulmatrix, Inc. |
$ 62 |
- |
$ -21 |
- |
| Pivot Pharmaceuticals Inc. |
$ 14 |
- |
$ -7 |
- |
| Q Biomed Inc. |
$ 27 |
$ 0 |
$ -9 |
8 |
| Quidel Corp |
$ 2,436 |
$ 196 |
$ 17 |
- |
| Qiagen Nv |
$ 9,152 |
$ 1,502 |
$ 190 |
- |
| Quest Patent Research Corp |
$ 3 |
$ 7 |
$ -2 |
2 |
| Quotient Ltd |
$ 484 |
$ 27 |
$ -99 |
- |
| Quint Media Inc. |
- |
- |
$ 0 |
- |
| Rasna Therapeutics Inc. |
$ 19 |
- |
$ -2 |
- |
| Rich Pharmaceuticals, Inc. |
$ 0 |
- |
$ 0 |
- |
| Regenocell Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Receptos, Inc. |
- |
- |
$ 0 |
- |
| Ridgefield Acquisition Corp |
$ 3 |
- |
$ 0 |
- |
| Restorgenex Corp |
- |
- |
$ 0 |
- |
| Regen Biopharma Inc |
$ 0 |
- |
$ -2 |
- |
| Regado Biosciences Inc |
- |
- |
$ 0 |
- |
| Repligen Corp |
$ 2,700 |
$ 184 |
$ 23 |
- |
| Regenxbio Inc. |
$ 2,739 |
$ 219 |
$ 105 |
- |
| Regenerx Biopharmaceuticals Inc |
$ 26 |
$ 0 |
$ 0 |
- |
| Relmada Therapeutics, Inc. |
$ 46 |
- |
$ -17 |
- |
| Repros Therapeutics Inc. |
$ 25 |
$ 0 |
$ -14 |
- |
| Respirerx Pharmaceuticals Inc. |
$ 3 |
- |
$ -3 |
- |
| Aytu Bioscience, Inc. |
- |
- |
$ 0 |
- |
| Ruthigen, Inc. |
- |
- |
$ 0 |
- |
| Radient Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
| Strongbridge Biopharma Plc |
$ 281 |
$ 18 |
$ 32 |
- |
| Sangui Biotech International Inc. |
$ 5 |
$ 0 |
$ 0 |
- |
| Seattle Genetics Inc |
$ 9,067 |
$ 269 |
$ -63 |
- |
| Sangamo Therapeutics, Inc |
$ 911 |
$ 84 |
$ -69 |
- |
| Shengtai Pharmaceutical, Inc. |
- |
- |
$ 0 |
- |
| Skinovation Pharmaceutical Inc |
- |
- |
$ 0 |
- |
| Skinvisible Inc |
$ 48 |
$ 1 |
$ -1 |
- |
| Sun Biopharma, Inc. |
$ 15 |
- |
$ -6 |
- |
| Syndax Pharmaceuticals Inc |
$ 137 |
$ 2 |
$ -78 |
- |
| Soligenix, Inc. |
$ 17 |
$ 6 |
$ -8 |
- |
| Senesco Technologies Inc |
- |
- |
$ 0 |
- |
| Senesco Technologies Inc |
- |
- |
$ -8 |
- |
| Microbot Medical Inc. |
- |
- |
$ -6 |
- |
| Spotlight Innovation Inc. |
$ 1 |
$ 0 |
$ -4 |
2 |
| Sunwin Stevia International, Inc. |
- |
- |
$ 0 |
- |
| Intellicell Biosciences, Inc. |
- |
- |
$ 0 |
- |
| Savient Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Sevion Therapeutics, Inc. |
$ 12 |
- |
$ -6 |
- |
| Tobira Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Tracon Pharmaceuticals, Inc. |
$ 44 |
$ 11 |
$ -35 |
- |
| Techne Corp |
$ 7,119 |
$ 330 |
$ 114 |
- |
| Telik Inc |
- |
- |
$ 0 |
- |
| Mabvax Therapeutics Holdings, Inc. |
- |
- |
$ 0 |
- |
| Tongli Pharmaceuticals (usa), Inc. |
$ 0 |
- |
$ 0 |
- |
| Tg Therapeutics, Inc. |
$ 538 |
$ 0 |
$ -173 |
- |
| Tg Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Twinlab Consolidated Holdings, Inc. |
$ 153 |
$ 76 |
$ -49 |
- |
| Teligent, Inc. |
$ 62 |
$ 60 |
$ -33 |
- |
| True Nature Holding, Inc. |
$ 4 |
- |
$ -1 |
1 |
| Targeted Medical Pharma, Inc. |
- |
- |
$ 0 |
- |
| Targacept Inc |
- |
- |
$ 0 |
- |
| Trovagene, Inc. |
$ 29 |
$ 0 |
$ -19 |
- |
| Therapeutic Solutions International, Inc. |
$ 4 |
$ 0 |
$ -1 |
- |
| Trius Therapeutics Inc |
- |
- |
$ 0 |
- |
| Taxus Pharmaceuticals Holdings, Inc. |
- |
- |
$ 0 |
- |
| Global Group Enterprises Corp. |
$ 311 |
- |
$ -15 |
- |
| Uluru Inc. |
$ 9 |
$ 1 |
$ -2 |
- |
| United Bancshares Inc |
- |
- |
$ 0 |
- |
| Stevia First Corp. |
$ 29 |
$ 0 |
$ -5 |
- |
| Vericel Corp |
$ 792 |
$ 91 |
$ -8 |
- |
| Vical Inc |
$ 27 |
$ 2 |
$ -16 |
- |
| Meridian Bioscience Inc |
$ 709 |
$ 185 |
$ 36 |
- |
| Volitionrx Ltd |
$ 110 |
- |
$ -18 |
- |
| Viropharma Inc |
- |
- |
$ 0 |
- |
| Vermillion, Inc. |
$ 102 |
$ 3 |
$ -12 |
- |
| Vistagen Therapeutics, Inc. |
$ 48 |
- |
$ -6 |
- |
| Vistagen Therapeutics, Inc. |
$ 41 |
- |
$ 0 |
- |
| Ventrus Biosciences Inc |
- |
- |
$ 0 |
- |
| Voyager Therapeutics, Inc. |
$ 581 |
$ 0 |
$ -88 |
- |
| Warner Chilcott Plc |
- |
- |
$ 0 |
- |
| Windtree Therapeutics Inc |
$ 16 |
$ 2 |
$ -9 |
- |
| Weikang Bio-technology Group Co., Inc. |
- |
- |
$ 0 |
- |
| Wave Life Sciences Ltd. |
$ 1,237 |
$ 14 |
$ -147 |
- |
| Xenetic Biosciences, Inc. |
$ 18 |
- |
$ -1 |
- |
| Acceleron Pharma Inc |
$ 2,042 |
$ 14 |
$ -119 |
- |
| Xstelos Holdings, Inc. |
- |
- |
$ 0 |
- |
| Zlato Inc. |
- |
$ 0 |
$ -6 |
1 |
| Artelo Biosciences, Inc. |
$ 17 |
- |
$ 0 |
- |
| Iovance Biotherapeutics, Inc. |
$ 1,141 |
- |
$ -124 |
- |
| G1 Therapeutics, Inc. |
$ 537 |
- |
$ -85 |
- |
| Aerpio Pharmaceuticals, Inc. |
$ 46 |
- |
$ -10 |
- |
| Dare Bioscience, Inc. |
$ 19 |
- |
$ -8 |
- |
| Sienna Biopharmaceuticals, Inc. |
$ 53 |
- |
$ -73 |
- |
| Propanc Biopharma, Inc. |
$ 1 |
- |
$ -7 |
- |
| Qrons Inc. |
$ 17 |
- |
$ -2 |
- |
| Novus Therapeutics, Inc. |
$ 40 |
- |
$ -7 |
- |
| Achieve Life Sciences, Inc. |
$ 35 |
- |
$ 0 |
- |
| Krystal Biotech, Inc. |
$ 266 |
- |
$ -5 |
- |
| Allena Pharmaceuticals, Inc. |
$ 145 |
- |
$ -36 |
- |
| Innovate Biopharmaceuticals, Inc. |
$ 52 |
- |
$ -24 |
- |
| Urogen Pharma Ltd. |
$ 2,235 |
$ 8 |
$ -20 |
- |
| Melinta Therapeutics, Inc. |
$ 164 |
$ 96 |
$ -157 |
- |
| Eloxx Pharmaceuticals, Inc. |
$ 414 |
- |
$ -47 |
- |
| Cv Sciences, Inc. |
$ 1,735 |
$ 59 |
$ 12 |
- |
| Soleno Therapeutics Inc |
$ 54 |
- |
$ -13 |
- |
| Nightstar Therapeutics Plc |
$ 1,530 |
- |
$ -67 |
- |
| Sellas Life Sciences Group, Inc. |
$ 25 |
$ 2 |
$ -37 |
- |
| Zymeworks Inc. |
$ 473 |
$ 53 |
$ -37 |
- |
| Scpharmaceuticals Inc. |
$ 55 |
- |
$ -29 |
- |
| Eyepoint Pharmaceuticals, Inc. |
$ 39 |
- |
$ 7 |
- |
| Solid Biosciences Inc. |
$ 355 |
- |
$ -75 |
- |
| Denali Therapeutics Inc. |
$ 1,835 |
$ 129 |
$ -36 |
- |
| Cue Biopharma, Inc. |
$ 161 |
- |
$ -39 |
- |
| Arcturus Therapeutics Ltd. |
$ 104 |
$ 29 |
$ -33 |
- |
| Homology Medicines, Inc. |
$ 968 |
$ 4 |
$ -57 |
- |
| Nymox Pharmaceutical Corporation |
- |
- |
$ 0 |
- |
| Cohbar, Inc. |
$ 132 |
- |
$ -16 |
- |
| Surface Oncology, Inc. |
$ 111 |
$ 59 |
$ -7 |
- |
| Evelo Biosciences, Inc. |
$ 258 |
- |
$ -57 |
- |
| Unity Biotechnology, Inc. |
$ 338 |
- |
$ -76 |
- |
| Tribus Enterprises, Inc. |
$ 17 |
$ 42 |
$ -38 |
- |
| Bionovate Technologies Corp. |
$ 17 |
- |
$ 0 |
- |
| Aptose Biosciences Inc. |
$ 230 |
- |
$ -41 |
- |
| Cellect Biotechnology Ltd. |
$ 129 |
- |
$ 20 |
- |
| Sesen Bio, Inc. |
$ 46 |
- |
$ 0 |
- |
| Genetic Technologies Ltd |
- |
$ 0 |
$ -5 |
- |
| Bionano Genomics, Inc |
$ 64 |
- |
$ 0 |
- |
| Aravive, Inc. |
$ 128 |
- |
$ 0 |
- |
| Urovant Sciences Ltd. |
$ 341 |
- |
$ 0 |
- |
| Cellectis S.a. |
$ 710 |
$ 13 |
$ -88 |
- |
| Apollo Endosurgery, Inc. |
$ 88 |
$ 61 |
$ -46 |
- |
| Biotechnology & Drugs Industry |
$ 596,831 |
$ 130,618 |
$ 3,016 |
89,094 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry. |
Earnings Estimates
decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
| Cardiovascular Segment |
| Revenues |
Income |
|
- |
- |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Neuroscience Segment |
| Revenues |
Income |
|
- |
- |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Anti-Infective Segment |
| Revenues |
Income |
|
14.75% |
-7.45% |
23.14% |
-12.12% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Respiratory Segment |
| Revenues |
Income |
|
- |
- |
- |
- |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|
Tweet
